Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Ventavis
Revenue, means the sales value of Ventavis
This report studies sales (consumption) of Ventavis in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer, Inc. (US)
Sanofi S.A (France)
Bayer HealthCare Pharmaceuticals (Germany)
Actelion Pharmaceuticals Ltd. (Switzerland)
Daiichi Sankyo Co., Ltd. (Japan)
Eli Lilly and Company (US)
YM BioSciences, Inc. (Canada)
GlaxoSmithKline Plc (UK)
Nippon Shinyaku Co., Ltd. (Japan)
Cipla Limited (India)
Arena Pharmaceuticals, Inc. (US)
The Novartis Group (Switzerland)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Ventavis in each application, can be divided into
Application 1
Application 2
Application 3
United States Ventavis Market Report 2016
1 Ventavis Overview
1.1 Product Overview and Scope of Ventavis
1.2 Classification of Ventavis
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Ventavis
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Ventavis (2011-2021)
1.4.1 United States Ventavis Sales and Growth Rate (2011-2021)
1.4.2 United States Ventavis Revenue and Growth Rate (2011-2021)
2 United States Ventavis Competition by Manufacturers
2.1 United States Ventavis Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Ventavis Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Ventavis Average Price by Manufactures (2015 and 2016)
2.4 Ventavis Market Competitive Situation and Trends
2.4.1 Ventavis Market Concentration Rate
2.4.2 Ventavis Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Ventavis Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Ventavis Sales and Market Share by Type (2011-2016)
3.2 United States Ventavis Revenue and Market Share by Type (2011-2016)
3.3 United States Ventavis Price by Type (2011-2016)
3.4 United States Ventavis Sales Growth Rate by Type (2011-2016)
4 United States Ventavis Sales (Volume) by Application (2011-2016)
4.1 United States Ventavis Sales and Market Share by Application (2011-2016)
4.2 United States Ventavis Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Ventavis Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Ventavis Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Sanofi S.A (France)
5.2.2 Ventavis Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Sanofi S.A (France) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Bayer HealthCare Pharmaceuticals (Germany)
5.3.2 Ventavis Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Bayer HealthCare Pharmaceuticals (Germany) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Actelion Pharmaceuticals Ltd. (Switzerland)
5.4.2 Ventavis Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Actelion Pharmaceuticals Ltd. (Switzerland) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Daiichi Sankyo Co., Ltd. (Japan)
5.5.2 Ventavis Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Daiichi Sankyo Co., Ltd. (Japan) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Eli Lilly and Company (US)
5.6.2 Ventavis Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Eli Lilly and Company (US) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 YM BioSciences, Inc. (Canada)
5.7.2 Ventavis Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 YM BioSciences, Inc. (Canada) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 GlaxoSmithKline Plc (UK)
5.8.2 Ventavis Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 GlaxoSmithKline Plc (UK) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Nippon Shinyaku Co., Ltd. (Japan)
5.9.2 Ventavis Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Nippon Shinyaku Co., Ltd. (Japan) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Cipla Limited (India)
5.10.2 Ventavis Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Cipla Limited (India) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Arena Pharmaceuticals, Inc. (US)
5.12 The Novartis Group (Switzerland)
6 Ventavis Manufacturing Cost Analysis
6.1 Ventavis Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Ventavis
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Ventavis Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Ventavis Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Ventavis Market Forecast (2016-2021)
10.1 United States Ventavis Sales, Revenue Forecast (2016-2021)
10.2 United States Ventavis Sales Forecast by Type (2016-2021)
10.3 United States Ventavis Sales Forecast by Application (2016-2021)
10.4 Ventavis Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Ventavis
Table Classification of Ventavis
Figure United States Sales Market Share of Ventavis by Type in 2015
Table Application of Ventavis
Figure United States Sales Market Share of Ventavis by Application in 2015
Figure United States Ventavis Sales and Growth Rate (2011-2021)
Figure United States Ventavis Revenue and Growth Rate (2011-2021)
Table United States Ventavis Sales of Key Manufacturers (2015 and 2016)
Table United States Ventavis Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ventavis Sales Share by Manufacturers
Figure 2016 Ventavis Sales Share by Manufacturers
Table United States Ventavis Revenue by Manufacturers (2015 and 2016)
Table United States Ventavis Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Ventavis Revenue Share by Manufacturers
Table 2016 United States Ventavis Revenue Share by Manufacturers
Table United States Market Ventavis Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Ventavis Average Price of Key Manufacturers in 2015
Figure Ventavis Market Share of Top 3 Manufacturers
Figure Ventavis Market Share of Top 5 Manufacturers
Table United States Ventavis Sales by Type (2011-2016)
Table United States Ventavis Sales Share by Type (2011-2016)
Figure United States Ventavis Sales Market Share by Type in 2015
Table United States Ventavis Revenue and Market Share by Type (2011-2016)
Table United States Ventavis Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ventavis by Type (2011-2016)
Table United States Ventavis Price by Type (2011-2016)
Figure United States Ventavis Sales Growth Rate by Type (2011-2016)
Table United States Ventavis Sales by Application (2011-2016)
Table United States Ventavis Sales Market Share by Application (2011-2016)
Figure United States Ventavis Sales Market Share by Application in 2015
Table United States Ventavis Sales Growth Rate by Application (2011-2016)
Figure United States Ventavis Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Ventavis Sales Market Share (2011-2016)
Table Sanofi S.A (France) Basic Information List
Table Sanofi S.A (France) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A (France) Ventavis Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Bayer HealthCare Pharmaceuticals (Germany) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Ventavis Sales Market Share (2011-2016)
Table Actelion Pharmaceuticals Ltd. (Switzerland) Basic Information List
Table Actelion Pharmaceuticals Ltd. (Switzerland) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actelion Pharmaceuticals Ltd. (Switzerland) Ventavis Sales Market Share (2011-2016)
Table Daiichi Sankyo Co., Ltd. (Japan) Basic Information List
Table Daiichi Sankyo Co., Ltd. (Japan) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Co., Ltd. (Japan) Ventavis Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Ventavis Sales Market Share (2011-2016)
Table YM BioSciences, Inc. (Canada) Basic Information List
Table YM BioSciences, Inc. (Canada) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Table YM BioSciences, Inc. (Canada) Ventavis Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Ventavis Sales Market Share (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Basic Information List
Table Nippon Shinyaku Co., Ltd. (Japan) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Ventavis Sales Market Share (2011-2016)
Table Cipla Limited (India) Basic Information List
Table Cipla Limited (India) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Limited (India) Ventavis Sales Market Share (2011-2016)
Table Arena Pharmaceuticals, Inc. (US) Basic Information List
Table Arena Pharmaceuticals, Inc. (US) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals, Inc. (US) Ventavis Sales Market Share (2011-2016)
Table The Novartis Group (Switzerland) Basic Information List
Table The Novartis Group (Switzerland) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)
Table The Novartis Group (Switzerland) Ventavis Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ventavis
Figure Manufacturing Process Analysis of Ventavis
Figure Ventavis Industrial Chain Analysis
Table Raw Materials Sources of Ventavis Major Manufacturers in 2015
Table Major Buyers of Ventavis
Table Distributors/Traders List
Figure United States Ventavis Production and Growth Rate Forecast (2016-2021)
Figure United States Ventavis Revenue and Growth Rate Forecast (2016-2021)
Table United States Ventavis Production Forecast by Type (2016-2021)
Table United States Ventavis Consumption Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...